From: Identification and validation of genes involved in gastric tumorigenesis
SNO | GENE SYMBOL | UPREGULATION REPORTED IN | REFERENCE |
---|---|---|---|
1 | CCL15/MIP5/MIP-1d/LKN1 | NSCLC | [SF5-R1] |
2 | ASPN | breast cancer | [SF5-R2] |
3 | MMP3 | colorectal cancer | [SF5-R3] |
4 | SPON2 | Lung, ovarian, prostate cancers | [SF5-R4] [SF5-R5] [SF5-R6] |
5 | PRSS22 | ovarian cancer | [SF5-R7] |
6 | CCL3/MIP 1A | oral SCC | [SF5-R8] |
7 | TMEPAI/PMEPAI | Neuro-endocrine tumours | [SF5-R9] |
8 | SIX3 | Â | Â |
9 | MFNG | Downregulated in cervical cancer | [SF5-R10] |
10 | SGNE1/SCG5 | endocrine tumors | Â |
11 | SOSTDC1 | Downregulated in renal cancer | [SF5-R11] |
12 | SST | Downregulated in oesophageal adenocarcinoma | [SF5-R12] |
13 | IGHA1 | Â | Â |
14 | AKR1B10 | Increased in Barrett's epithelium | [SF5-R13] |
15 | FCGBP | Down regulated in colon ca | [SF5-R14] |
16 | ATP4B | Â | Â |
17 | NCAPH2 | Â | Â |